Metraipolis › archive › dc_f06e6220df3d
Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety — Europe PMC PMID:42292432
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42292432
- DOI
- 10.3389/fimmu.2026.1762151
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:04:11.331Z
- SHA-256 of the archived text
0041fc5967b8109ffc41482b714d4720b6a5c87020defea5a1eeddc307a1ed33- Stable URL of this page
https://metraipolis.com/documento/dc_f06e6220df3d
How to cite
Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety — Europe PMC PMID:42292432 — Europe PMC (en), https://europepmc.org/article/MED/42292432 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f06e6220df3d (Metraipolis archive dc_f06e6220df3d, sha256 0041fc5967b8109ffc41482b714d4720b6a5c87020defea5a1eeddc307a1ed33)
BibTeX
@misc{dcf06e6220df3d,
title = {Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety — Europe PMC PMID:42292432},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42292432},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f06e6220df3d; sha256 0041fc5967b8109ffc41482b714d4720b6a5c87020defea5a1eeddc307a1ed33},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292432. Agents can read the archived copy with the MCP tool read_document.